Department of Neurology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Mult Scler. 2011 Apr;17(4):382-8. doi: 10.1177/1352458510391345. Epub 2010 Dec 21.
The association of human leukocyte antigen (HLA) genes and multiple sclerosis (MS) has been extensively investigated in Caucasians, but less so in Oriental races such as Chinese.
To review studies on association of HLA class II alleles with MS in the Chinese population.
An extensive search for published studies up to June 2010 was performed in the electronic databases. The meta-analysis facilities in the NCSS statistical package were utilized to analyze the findings in these studies. The odds ratios (ORs) of HLA-DR allele distributions in MS were analyzed against controls.
Eleven case-control studies were identified: nine genotyping and two serotyping studies. Six genotyping studies were suitable for HLA-DRB1 allele meta-analysis, which showed that HLA-DRB115 was associated with risk of MS in the combined group (308 cases and 407 controls; OR 1.39) while the HLA-DRB109 and HLA-DRB1*0901 alleles were protective. When the equivalent serotypes in these six studies were combined with the results from the two serotyping studies (431 cases and 652 controls) for a meta-analysis of HLA-DR serotypes, HLA-DR2 was a risk factor (OR 1.63) and HLA-DR9 was strongly protective in the combined group (OR 0.64).
Although limited data are available, our meta-analysis suggests that HLA-DR2/DRB1*15 are also associated with risk of MS in the Chinese population but less strongly so than in Western MS populations, whereas HLA-DR9 alleles appear to confer resistance in this population.
人类白细胞抗原(HLA)基因与多发性硬化症(MS)的关联已在白种人中进行了广泛研究,但在亚洲人群如中国人中研究较少。
综述 HLA Ⅱ类等位基因与中国人 MS 易感性的相关研究。
在电子数据库中对截至 2010 年 6 月发表的研究进行了广泛检索。使用 NCSS 统计软件包中的荟萃分析功能对这些研究中的发现进行分析。分析 MS 患者 HLA-DR 等位基因分布的比值比(OR)与对照组相比。
共鉴定出 11 项病例对照研究:9 项基因分型和 2 项血清分型研究。6 项基因分型研究适合 HLA-DRB1 等位基因荟萃分析,结果表明 HLA-DRB115 与合并组(308 例和 407 例对照;OR 1.39)的 MS 风险相关,而 HLA-DRB109 和 HLA-DRB1*0901 等位基因具有保护作用。当将这 6 项研究中的等效血清型与 2 项血清分型研究(431 例和 652 例对照)的结果合并进行 HLA-DR 血清型荟萃分析时,HLA-DR2 是一个危险因素(OR 1.63),HLA-DR9 在合并组中具有很强的保护作用(OR 0.64)。
尽管数据有限,但我们的荟萃分析表明,HLA-DR2/DRB1*15 也与中国人 MS 易感性相关,但与西方 MS 人群相比,相关性较弱,而 HLA-DR9 等位基因似乎在该人群中具有抵抗作用。